Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05326386 · ClinicalTrials.gov registry record · NA
Gamification and Medication Adherence (GAME Adherence)
A NA study of Hypertension and Hyperlipidemia, sponsored by University of Pennsylvania.
- Active
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT05326386 is a NA study of Hypertension and Hyperlipidemia that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 84 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05326386, a NA study of Hypertension and Hyperlipidemia, is active but no longer recruiting, sponsored by University of Pennsylvania.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
A two-arm randomized controlled trial to evaluate whether a gamification intervention plus involvement of a supportive partner (social support) and sending reports to physicians (accountability) increases medication adherence in patients with hypertension and hyperlipidemia. The study will randomize 84 patients with hypertension, hyperlipidemia, and a history of poor medication adherence seen in a single Penn Medicine clinic to an 18-week gamification intervention or to attention control text messages alone.
Conditions Studied
Interventions
- BEHAVIORAL HTN and Medication Adherence
Study Locations (1)
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2022-09-12 |
| Est. Completion | 2026-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05326386
The ClinicalTrials.gov registry entry for NCT05326386 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension and Hyperlipidemia appearing as the primary indexed condition, and to 1 intervention - of which HTN and Medication Adherence is the first listed.
NCT05326386 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05326386 about?
NCT05326386 is a clinical study titled "Gamification and Medication Adherence (GAME Adherence)". A two-arm randomized controlled trial to evaluate whether a gamification intervention plus involvement of a supportive partner (social support) and sending reports to physicians (accountability) increases medication adherence in patients with hypertension and hyperlipidemia. The study will randomize...
What is the current status of trial NCT05326386?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2022-09-12. Estimated completion is 2026-05.
What conditions does trial NCT05326386 study?
This clinical trial studies the following conditions: Hypertension and Hyperlipidemia.
What interventions are being tested in trial NCT05326386?
The interventions under investigation include: HTN and Medication Adherence (BEHAVIORAL).
Who is sponsoring clinical trial NCT05326386?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05326386 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.